Navigation Links
Review Spotlights Clues to Serious Childhood Infection
Date:2/4/2010

Signs may not be recognized because they are rare in developed countries, authors say

THURSDAY, Feb. 4 (HealthDay News) -- Rapid breathing, poor blood circulation and, possibly, parental concern and a doctor's instinct are potential warning signs of serious infection among children in developed countries, according to a review of published research.

The researchers analyzed the findings of 30 studies assessing clinical features of serious infection in children and found that cyanosis (blue skin resulting from lack of oxygen), rapid breathing, poor blood circulation and petechial rash (small purple/red spots) were identified as red flags in several of the studies.

One study said parental concern and a doctor's instinct were strong warning signs.

"The main strength of this systematic review is that it highlights the nature and difficulty of the diagnostic task facing primary care and hospital clinicians responsible for identifying seriously ill children at initial presentation in countries where serious childhood illness is now rare," wrote Dr. Ann Van den Bruel, of the department of general practice at Katholieke Universiteit Leuven, Belgium, and colleagues.

"Most of the red flags already recommended by the World Health Organization for use in developing countries can be used in the initial assessment of children presenting to ambulatory care settings in developed countries. There should be more emphasis on parental concern in the diagnostic process," they concluded.

"However, we now need to identify the level of risk at which clinical action should be taken. Additionally, the relative inability of any combination of clinical features to effectively exclude the possibility of serious illness in a one-off consultation means that parents need to be more actively involved in monitoring red flags and taking precautionary measures," the authors wrote.

The review is published in the Feb. 3 online edition of The Lancet.

"What is clear is that in 2010 we do not know how to effectively recognize or rule out severe disease in ill children and what is more, we do not even have a cohesive national or a global research strategy to address this problem. Notably, of the 30 studies included in today's review, only one was in primary care, where the problem is most frequently present," Dr. Martin Dawes of McGill University in Montreal, Canada, wrote in an accompanying editorial.

More information

The Nemours Foundation has more about children and infections.



-- Robert Preidt



SOURCE: The Lancet, news release, Feb. 2, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. SIS Rules-Based Charging Solution Successfully Peer Reviewed by HFMA for Third Consecutive Year
2. Peer Review Experts Have Weighed In ... WEIGHLEVEL Is a Proven Winner
3. Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
4. HCA Previews Fourth Quarter and Year-End 2009 Results
5. BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package
6. Hearing Aid Reviews Go Public on Advice on Hearing Aids
7. Morehead Presents Webinar on “The State of Physician Engagement: A Year in Review”
8. Gilbert Hospital 2009 Emergency Department Year in Review
9. Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review"
10. New England Journal of Medicine publishes CWRU review of the molecular basis of colorectal cancer
11. Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Farmingdale, NY (PRWEB) , ... March 27, 2017 ... ... specializing in epigenetic research products enables researchers to pursue the recent RNA methylation ... RNA methylation . In light of the newfound characteristics of N6-methyladenosine, or ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare ... will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will ... chain and value analysis professionals have a ‘seat at the table’ with clinical ...
(Date:3/27/2017)... ... ... According to the American Cancer Society , the average 15-year survival ... the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year survival ... latter group, tune in to Lifestyle Magazine on April 9, 2017, to ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... agreement to resolve the pending litigation between itself and 1800 Vending DBA Healthy ... Utah). , “I am thrilled to announce that we have now reached a ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology: